Current guidelines for the management of patients with stable coronary heart disease (CHD) emphasize accurate risk assessment for determining optimal treatment strategies and go on to suggest that the absolute mortality benefit of coronary artery bypass grafting (CABG) is greatest among those at highest risk on the basis of an analysis of the CABG Trialists Collaboration (6, 7) . In contrast, the more recent STICH has reported that she has no relationships relevant to the contents of this paper to disclose. 
